Back

Discussant review - STEP HFpEF Program

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Late breaking clinical trials: further analyses and baseline characteristics Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Antoni Bayes Genis

University Hospital Germans Trias and Pujol de Badalona, Badalona (Spain)

9 More presentations in this session

Presentation thumbnail
Effect of IV iron in patients with heart failure with preserved ejection fraction
Professor S. von Haehling (Goettingen, DE)
Slides Video
Presentation thumbnail
Discussant review - FAIR-HFpEF
Professor P. Kalra (Portsmouth, GB)
Slides Video
Presentation thumbnail
Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF: insights from the STEP-HFpEF programme
Professor M. Petrie (Glasgow, GB)
Slides Video
Presentation thumbnail
Design and baseline characteristics of REALIZE K: a placebo-controlled randomized-withdrawal trial of sodium zirconium cyclosilicate for hyperkalaemia management in patients with HF and reduced EF
Doctor M. Kosiborod (Kansas City, US)
Slides Video
Presentation thumbnail
Discussant review - REALIZE-K
Professor G. Rosano (London, GB)
Slides Video

Access the full session

Session thumbnail
Late breaking clinical trials: further analyses and baseline characteristics
Video

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Semaglutide 2.4 mg and NTproBNP in obesity-related HFpEF: insights from the STEP-HFpEF programme
thumbnail
Congress Presentation
Discussant review - STEP-HFpEF Programme
thumbnail
Congress Presentation
Novel medical approach to treating obesity

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources